Essa Bancorp, which belongs to the Zacks Financial - Savings and Loan industry, posted revenues of $16.28 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 5.82%. This compares to year-ago revenues of $17.18 million. The company has topped consensus revenue estimates two times over the last four quarters. This quarterly report represents an earnings surprise of -8.89%. A quarter ago, it was expected that this bank would post earnings of $0.35 per share when it actually produce ...

Essa Bancorp (ESSA) shares rallied 5.4% in the last trading session to close at $19.50. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 11.5% gain over the past four weeks. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements ...

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 8, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will present at the JonesHealthcare Seaside Summit on Monday, July 15, 2024 at 11:00 a.m. PT. David R. Parkinson, President and Chief Executive Officer, will host the presentation and will also participate in a panel discussion ...

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, May 30, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 p.m. ET in New York. David. R. Parkinson, President, and Chief Executive Officer and David S. Wood, Chief Financial Officer, wil ...

Business Overview EPIX is a clinical-stage pharmaceutical company focused on developing therapies for prostate cancer. It was founded in 2009 and operates in Houston, San Francisco, and Vancouver. Today, EPIX's science focuses on therapies designed to disrupt the androgen receptor [AR] using N-terminal Domain [NTD] inhibitors called Anitens to inhibit cancer growth. Prostate cancer is the most common cancer in men in the U.S. and the second cause of male cancer deaths. About 1 in 8 men will be diagnosed wit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2024 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to __________ Commission File No. 001-33384 ESSA Bancorp, Inc. (Exact name of registrant as specified in its charter) Pennsylvania 20-8023072 (State or other jurisdictio ...

Exhibit 99.1 ESSA Bancorp, Inc. Announces Fiscal Second Quarter and Fiscal First Half 2024 Financial Results Stroudsburg, PA. – April 24, 2024 — ESSA Bancorp, Inc. (the “Company”) (NASDAQ:ESSA), the holding company for ESSA Bank & Trust (the “Bank”), a $2.2 billion asset financial institution providing full service commercial and retail banking, financial, and investment services in eastern Pennsylvania, today announced financial results for the fiscal second quarter and fiscal first half periods ended Marc ...

Essa Bancorp (ESSA) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.48 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 37.14%. A quarter ago, it was expected that this bank would post earnings of $0.46 per share when it actually produced earnings of $0.45, delivering a surprise of -2.17%.Over the last four quarters, the company has su ...

Essa Bancorp (ESSA) shares rallied 7.1% in the last trading session to close at $17.21. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.8% loss over the past four weeks.With the U.S. economy showing no signs of slowing down and the Federal Reserve still expected to cut rates this year, banking sector is in the spotlight. Hence, investors are showing optimistic stance on the sector and this is likely to hav ...

Essa Bancorp (ESSA) shares ended the last trading session 7.2% higher at $18.44. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 7.7% loss over the past four weeks.After getting hammered because of industry-wide concern related to commercial real estate (CRE) loans, shares of Essa Bancorp are showing signs of improvement. Given the company’s notable CRE loan exposure, the Federal Reserve’s signal of rate cuts later ...